Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

Generic Drugs Come of Age

Generic-drug manufacturers look to expand into biologics and complex dosage forms. This article contains bonus online-exclusive material.
Dec 2, 2009

Generic-drug manufacturers look to expand into biologics and complex dosage forms. This article contains bonus online-exclusive material.

Safety versus Speed in Drug Development

The heightened focus on risk raises concerns about delays in approving new drugs.
Nov 2, 2009

The heightened focus on risk raises concerns about delays in approving new drugs.

New Leadership Seeks to Transform FDA

Strict enforcement, new rules, and organizational changes signal an activist tone.
Oct 2, 2009

Strict enforcement, new rules, and organizational changes signal an activist tone.

Global Health Concerns Create Business Opportunities

Health crises generate support for new vaccines and treatments for diseases found in developing nations.
Sep 2, 2009

Health crises generate support for new vaccines and treatments for diseases found in developing nations.

Pharma Girds for Healthcare Reform

Pressure to reduce healthcare spending has put drug rebates, price cuts, and tax hikes on the table.
Aug 2, 2009

Pressure to reduce healthcare spending has put drug rebates, price cuts, and tax hikes on the table.

Manufacturers Face New Risk-Management Requirements

REMS to improve the safe use of opioids may lead to controls on other high-risk medicines.
Jul 2, 2009

REMS to improve the safe use of opioids may lead to controls on other high-risk medicines.

FDA Commissioner Hamburg Discusses Drug Regulation

Jun 22, 2009

The new commissioner of the US Food and Drug Administration is mapping plans for turning around an agency that has been demoralized, buffeted about in the press and has lost some of the trust of the American people.

FDA Waves a Big Stick

Agency officials and manufacturers anticipate stricter enforcement of drug safety and quality.
Jun 2, 2009

Agency officials and manufacturers anticipate stricter enforcement of drug safety and quality.

The Comparative-Effectiveness Controversy

Government funding is slated to boost comparative studies of prescription drugs.
May 2, 2009

Government funding is slated to boost comparative studies of prescription drugs.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here